Speech Performance and Clinic Efficiency With Remote Care Compared With Standard of Care in Adults With a Cochlear Implant in the First 12 Months Post-activation

Inclusion Criteria:

• Aged 18 years or older (no upper age limit)

• Post-lingually deafened

• Unilaterally implanted with the CI600 Series (CI612, CI622, CI632),CI500 Series (CI512, CI522, CI532) or Freedom Series (CI24RE(CA),CI24RE(ST), CI422)

• Currently using a Nucleus 7 (CP1000) or Kanso 2 (CP1050) Sound Processor (or latestcompatible Sound Processor)

• 3 months, +/- 2 weeks, experience with a cochlear implant (post-activation) at thetime of baseline measurements

• Owner of a compatible Smart Phone

• Fluent in the languages used for the study, as determined by the investigator

• Willing to participate in and comply with all requirements of the protocol,including willingness to be randomised to either arm

• Willing and able to provide written informed consent

Exclusion Criteria:

• Patient has a MAP incompatible with Master Volume, Bass and Treble (MVBT)programming:

• Non-monopolar MAPs (bipolar, common ground, variable mode)

• Dynamic range of <10 Comfortable Level (CL)

• Hybrid mode enabled

• Pulse widths >100 µs

• 10 or more electrodes turned off

• Patient has on-going fluctuations in MAP Threshold levels (Ts) and Comfort levels (Cs) and/or impedances

• Patient requires frequent individual channel measurements and/or measurementswithout the use of live-stimulation

• Score below 3 on the screening subset of questions from the Mobile DeviceProficiency Questionnaire (MDPQ)

• Abnormal cochlea anatomy and/or facial nerve stimulation

• Additional disabilities that would prevent participation in evaluations, includingsignificant visual impairment and/or dexterity issues

• Unable or unwilling to comply with the requirements of the clinical investigation asdetermined by the Investigator

• Investigator site personnel directly affiliated with this study and/or theirimmediate families; immediate family is defined as a spouse, parent, child, orsibling

• Cochlear employees or employees of Contract Research Organisations or contractorsengaged by Cochlear for the purposes of this investigation

• Current participation, or participation in another interventional clinicalstudy/trial in the past 30 days, involving an investigational drug or device (unlessthe other investigation was/is a Cochlear sponsored investigation and determined bythe investigator or Sponsor to not impact this investigation).